We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.95B
AUM Growth
-$319M
Cap. Flow
-$362M
Cap. Flow %
-18.57%
Top 10 Hldgs %
50.07%
Holding
304
New
78
Increased
103
Reduced
62
Closed
60

Sector Composition

Rank Sector Weight
1 Financials 18.3%
2 Technology 15.69%
3 Industrials 13.34%
4 Communication Services 11.51%
5 Healthcare 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVOK
76
DELISTED
Seven Oaks Acquisition Corp. Class A Common Stock
SVOK
$5.02M 0.26%
505,458
-15,367
-3% -$152K
LCA
77
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$4.99M 0.26%
512,015
+1,228
+0.2% +$11.9K
CTV
78
DELISTED
Innovid Corp.
CTV
$4.95M 0.25%
+499,517
New +$4.93M
DGNS
79
DELISTED
Dragoneer Growth Opportunities Corp. II Class A Ordinary Shares
DGNS
$4.92M 0.25%
494,880
+256,974
+108% +$2.55M
SEAH
80
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
$4.82M 0.25%
+480,956
New +$4.79M
AUR icon
81
Aurora
AUR
$12.4B
$4.77M 0.24%
+480,461
New +$4.75M
VAQC
82
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$4.7M 0.24%
+482,183
New +$4.71M
TLSI icon
83
TriSalus Life Sciences
TLSI
$267M
$4.63M 0.24%
466,196
+245,225
+111% +$2.4M
YAC
84
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$4.59M 0.24%
464,209
+439,060
+1,746% +$4.34M
ISPO
85
DELISTED
Inspirato
ISPO
$4.54M 0.23%
+22,457
New +$4.51M
PSAG
86
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
$4.52M 0.23%
467,300
+5,216
+1% +$50.3K
DRAYU
87
DELISTED
Macondray Capital Acquisition Corp. I Unit
DRAYU
$4.49M 0.23%
+449,890
New +$4.47M
QTEK
88
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$4.47M 0.23%
+450,221
New +$4.45M
HLGN
89
DELISTED
Heliogen, Inc.
HLGN
$4.38M 0.22%
+12,596
New +$4.36M
DCGO icon
90
DocGo
DCGO
$63.5M
$4.21M 0.22%
422,759
+251,179
+146% +$2.5M
CLAS
91
DELISTED
Class Acceleration Corp.
CLAS
$3.96M 0.2%
407,993
+13,331
+3% +$129K
KWAC
92
DELISTED
Kingswood Acquisition Corp.
KWAC
$3.94M 0.2%
390,281
+15,832
+4% +$159K
BITE
93
DELISTED
Bite Acquisition Corp.
BITE
$3.92M 0.2%
402,537
+7,972
+2% +$77.1K
PRPB
94
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
$3.88M 0.2%
394,796
-3,271
-0.8% -$32.1K
FVIV
95
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$3.85M 0.2%
395,199
+4,808
+1% +$46.8K
IBER.U
96
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$3.83M 0.2%
383,033
+18,662
+5% +$186K
GLTA.U
97
DELISTED
Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant
GLTA.U
$3.71M 0.19%
+370,854
New +$3.71M
DAVE icon
98
Dave Inc
DAVE
$5.58B
$3.65M 0.19%
11,520
+6,050
+111% +$1.92M
GFX
99
DELISTED
Golden Falcon Acquisition Corp.
GFX
$3.6M 0.18%
368,914
+3,529
+1% +$34.3K
ETAC
100
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$3.53M 0.18%
359,576
-9,384
-3% -$91.7K

Similar funds

Omni Partners US's Q3 2021 Portfolio in Review

As of Q3 2021, Omni Partners US held 304 positions worth $1.95B, down 14% from $2.27B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Omni Partners US withdrew a net $362M in Q3 2021, closing 60 positions and reducing 62 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $326M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Omni Partners US opened a new position in Covanta Holding Corporation worth $56.8M.

  • Omni Partners US's largest Q3 2021 buy was Covanta Holding Corporation: 2,822,693 shares worth $56.8M.
  • Omni Partners US added most to Kansas City Southern in Q3 2021, an estimated $127M increase.
  • Omni Partners US's biggest Q3 2021 reduction was Change Healthcare Inc. Common Stock, cutting an estimated $37.2M.
  • Omni Partners US fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $326M.
  • Omni Partners US's ten largest holdings make up 50% of its $1.95B portfolio in Q3 2021.
  • Omni Partners US opened 78 new positions and closed 60 in Q3 2021.
  • Omni Partners US's portfolio value fell 14% quarter-over-quarter to $1.95B.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.